Results 81 to 90 of about 42,441 (299)

Outcomes of patients with continuous flow left ventricular assist device undergoing emergency endovascular treatment for atraumatic bleeding

CVIR Endovascular, 2019
Introduction Severe spontaneous bleeding is a significant complication in patients with continuous flow left ventricular assist devices; there is little evidence on endovascular treatment to support its use.
Valentina Bernardinello, Giulio Barbiero, Michele Battistel, Caterina Dengo, Roberto Stramare, Giulio Folino, Jonida Bejko, Massimiliano Carrozzini, Vincenzo Tarzia, Gino Gerosa, Tomaso Bottio   +10 more
doaj   +1 more source

Postoperative outcomes following rehabilitation in patients with left ventricular assist devices

Monaldi Archives for Chest Disease, 2020
Postoperative rehabilitation is a cornerstone of the recovery pathway following left ventricular assist device implantation (LVAD), and patients are expected to conduct an autonomous life thanks to improved technology and increased knowledge of ...
Massimiliano Polastri, Silvia Boschi, Giorgia Brillanti, Sofia Martin-Suarez, Marco Masetti, Luciano Potena, Antonio Loforte   +6 more
doaj   +1 more source

Right Ventricular Myocardial Infarction Complicated by Cardiac Arrest: Utilization of Extracorporeal Membrane Oxygenation

Case Reports in Cardiology, 2022
A 44-year-old male with an out-of-hospital cardiac arrest due to an acute left ventricular (LV) inferoposterior wall myocardial infarction (MI) involving the right ventricle (RV) is presented.
Alisha Alabre-Bonsu, Saurav Uppal, Ernest L. Mazzaferri, Konstantinos Dean Boudoulas   +3 more
doaj   +1 more source

From Rigid to Soft Robotic Approaches for Neuroendoscopy

Advanced Robotics Research, EarlyView.
Robotic assistance has had minimal impact on deep intraventricular surgeries, where small‐scale, precision, and reduced invasiveness can contribute to improved patient outcomes. Emerging technologies in rigid, soft, and hybrid robotics are reviewed to identify the most promising mechanisms for deep brain navigation in addition to an attempt to identify
Kieran Gilday, Irena Zubak, Andreas Raabe, Josie Hughes   +3 more
wiley   +1 more source

Emergent decommissioning of HeartMate 3 for life-threatening hemorrhage

Journal of Vascular Surgery Cases and Innovative Techniques
Left ventricular assist devices are known for the treatment of heart failure. We present a patient who underwent emergent decommissioning of his left ventricular assist device after experiencing life-threatening hemorrhage.
Reginald E. Du, MD, Ryan S. Bedi, MD, W. Charles Sternbergh, III, MD, Aditya Bansal, MD   +3 more
doaj   +1 more source

Finite Element Driven Design Domain Identification of a Beating Left Ventricular Simulator

Bioengineering, 2019
Almost ten percent of the American population have heart diseases. Since the number of available heart donors is not promising, left ventricular assist devices are implemented as bridge therapies.
Utku Gulbulak, Atila Ertas
doaj   +1 more source

Strategic Design of Soft Actuators in Translational Medical Robotics for Human‐Centered Healthcare

Advanced Robotics Research, EarlyView.
Soft robotics enables biocompatible, compliant medical devices, but clinical translation requires design‐driven engineering beyond materials. This perspective reviews implantable, surgical, and wearable systems by actuation mechanism, highlighting how optimized architectures and integration improve mechanical interfacing, adaptability, and durability ...
Ho Jun Jin, Jimin Kim, Inho Kim, Bong Hoon Kim   +3 more
wiley   +1 more source

Performance evaluation of a pulsatile ventricular assist device under non physiologic pumping frequencies by means FEM and 2D approach [PDF]

, 2017
A ventricular assist device (VAD) is a blood pump that works in parallel with heart. It is used as a mechanical assistance for patients that suffer cardiac insufficiency: as a therapy, as a bridge to transplant or to extend life.
Di Paolo, José, Fríes, Exequiel R.
core  

A novel closed-chest porcine model of chronic ischemic heart failure suitable for experimental research in cardiovascular disease [PDF]

, 2013
Cardiac pathologies are among the leading causes of mortality and morbidity in industrialized countries, with myocardial infarction (MI) representing one of the major conditions leading to heart failure (HF).
Antonio Amodeo, BIONDI ZOCCAI, GIUSEPPE, CALOGERO, ANTONELLA, CAVARRETTA, Elena, CHIMENTI, ISOTTA, DE FALCO, ELENA, Fabrizio D'Ascenzo, FRATI, GIACOMO, Luca Pacini, MANCONE, Massimo, Maria Emiliana Caristo, MARULLO, Antonino, Marzia Lotrionte, Omar Leoni, PERUZZI, MARIANGELA, PETROZZA, Vincenzo   +15 more
core   +3 more sources

ELABELA Targets Mitochondria to Modulate Heart Development

Advanced Science, EarlyView.
The role of peptide ELABELA (ELA) in cardiomyocyte apoptosis and congenital heart disease (CHD) is unclear. ELA deficiency caused cardiomyocyte apoptosis and CHD. A novel ELA‐APJ‐AKT‐BCL2/BAX axis in regulating mitochondrial function and contributing to CHD pathogenesis was established.
Jian Wang, Qingjie Wang, Zhikang Xu, Shuang Zhou, Yue Zhou, Junjie Yang, Lingfeng Tong, Zhuo Meng, Mei Yang, Wen Zhao, Tie Yang, Hualin Wang, Jun Zhang, Rubin Tan, Lei Wang, Yuqiang Huang, Bin Zhou, Sun Chen, Bing Zhang, Jinxiang Yuan, Jianyuan Zhao, Alex F. Chen, Kun Sun   +22 more
wiley   +1 more source